Senseonics (NYSE:SENS) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Senseonics (NYSE:SENS) in a report issued on Sunday morning. The brokerage issued a sell rating on the stock.

Separately, HC Wainwright reissued a “buy” rating and issued a $2.00 target price on shares of Senseonics in a research note on Friday, November 15th.

Senseonics Trading Down 2.1 %

Shares of SENS stock opened at $0.32 on Friday. The firm has a 50-day moving average price of $0.34 and a 200 day moving average price of $0.39. Senseonics has a twelve month low of $0.28 and a twelve month high of $0.75. The company has a debt-to-equity ratio of 59.17, a current ratio of 2.47 and a quick ratio of 2.38.

Institutional Trading of Senseonics

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. FMR LLC grew its holdings in Senseonics by 48,267.2% in the 3rd quarter. FMR LLC now owns 168,318 shares of the company’s stock valued at $59,000 after buying an additional 167,970 shares during the period. State Board of Administration of Florida Retirement System purchased a new stake in Senseonics in the 1st quarter valued at about $91,000. GSA Capital Partners LLP purchased a new stake in Senseonics in the 3rd quarter valued at about $117,000. Virtu Financial LLC purchased a new stake in Senseonics in the 1st quarter valued at about $162,000. Finally, Symmetry Partners LLC purchased a new stake in Senseonics in the 3rd quarter valued at about $164,000. Hedge funds and other institutional investors own 12.36% of the company’s stock.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.